Showing 341 - 360 results of 132,664 for search '(( 2 we decrease ) OR ( 5 ((((teer decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.68s Refine Results
  1. 341
  2. 342

    Linking Protective <i>GAB2</i> Variants, Increased Cortical <i>GAB2</i> Expression and Decreased Alzheimer’s Disease Pathology by Fanggeng Zou (159980)

    Published 2013
    “…Using a freely available database of lymphoblastoid cell lines we found that protective <i>GAB2</i> variants were associated with increased <i>GAB2</i> expression (p = 9.5×10<sup>−7</sup>−9.3×10<sup>−6</sup>). …”
  3. 343

    Statins impact primary embryonic mouse neural stem cell survival, cell death, and fate through distinct mechanisms by Ross A. Carson (5184512)

    Published 2018
    “…We found that statins dose dependently decrease NSPC expansion by promoting cell death and autophagy of NSPCs progressing through the G1 phase of the cell cycle. …”
  4. 344
  5. 345
  6. 346
  7. 347
  8. 348
  9. 349
  10. 350
  11. 351

    Downregulation of DOM decreases the abundance of PER and TIM. by Zhenxing Liu (399809)

    Published 2019
    “…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”
  12. 352

    Dramatic Lockdown Fossil Fuel CO<sub>2</sub> Decrease Detected by Citizen Science-Supported Atmospheric Radiocarbon Observations by Jocelyn C. Turnbull (6083705)

    Published 2022
    “…The local fossil fuel CO<sub>2</sub> mole fractions during lockdown were compared with a “normal” nonlockdown period. …”
  13. 353

    A decrease in the invasiveness of <i>Candida albicans</i> into Caco-2 cells parallels the differentiation of intestinal epithelial cells. by Marianne Goyer (2550589)

    Published 2016
    “…Caco-2 cell differentiation increased throughout the culture as highlighted by the increase in TEER measurements (Ω.cm<sup>2</sup>) (full line), which correlated with a decrease in <i>C</i>. …”
  14. 354

    Overview of the WeARTolerance program. by Ana Beato (20489933)

    Published 2024
    “…The quantitative results from Phase 1 demonstrated a decreasing trend in all primary outcomes. In phase 2, participants acknowledged the activities’ relevance, reported overall satisfaction with the program, and showed great enthusiasm and willingness to learn more. …”
  15. 355
  16. 356
  17. 357

    Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease by Sandra L. Dabora (206838)

    Published 2011
    “…<div><h3>Background</h3><p>Tuberous sclerosis (TSC) related tumors are characterized by constitutively activated mTOR signaling due to mutations in <em>TSC1</em> or <em>TSC2</em>.</p> <h3>Methods</h3><p>We completed a phase 2 multicenter trial to evaluate the efficacy and tolerability of the mTOR inhibitor, sirolimus, for the treatment of kidney angiomyolipomas.…”
  18. 358
  19. 359

    The Transition from a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk by Heba M Ismail (9568748)

    Published 2022
    “…Conclusions</p> <p>A transition from an increase to a decrease in AUC C-peptide approximately 1.5 years pre-diagnosis was validated in two independent cohorts. …”
  20. 360